Life Sciences
Will the Shifting Landscape of NGS Disrupt Genomics?
On this episode of GEN Live, sponsored by Element Biosciences, we’ll talk about genomics—as a tool and as a field. Where is it now and what type of…
Broadcast Date: January 18, 2023
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
2022 saw a surge of interest and competition in the next-gen sequencing (NGS) industry, as established companies were joined by a hungry group of new platforms.
Today, researchers who sequence DNA have choices that they simply have not had before.
On this episode of GEN Live, we’ll talk about genomics—as a tool and as a field. Where is it now and what type of research is NGS enabling? We’ll also get into the crowded NGS market—considering the recent announcements of new technologies, instruments, and companies in this space. What will it take for the new companies to compete? We’ll also touch on other questions, such as: is long-read sequencing poised to overtake the utility of short reads?
A live Q&A session followed the presentation, offering a chance to pose questions to our expert panelist.
Sponsored content brought to you by
The post Will the Shifting Landscape of NGS Disrupt Genomics? appeared first on GEN – Genetic Engineering and Biotechnology News.
Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….